ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 76 filers reported holding ESSA PHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $2,841,000 | -73.2% | 1,561,251 | -53.6% | 0.06% | -75.3% |
Q2 2022 | $10,602,000 | -58.9% | 3,365,568 | -19.3% | 0.23% | -43.8% |
Q1 2022 | $25,772,000 | -45.3% | 4,170,259 | +25.7% | 0.40% | -32.9% |
Q4 2021 | $47,125,000 | +170.1% | 3,318,647 | +52.2% | 0.60% | +161.7% |
Q3 2021 | $17,449,000 | -74.6% | 2,181,101 | -9.3% | 0.23% | -75.1% |
Q2 2021 | $68,716,000 | -1.7% | 2,405,169 | 0.0% | 0.92% | -10.8% |
Q1 2021 | $69,870,000 | +164.0% | 2,405,169 | +3.0% | 1.04% | +154.9% |
Q4 2020 | $26,466,000 | +72.9% | 2,335,169 | 0.0% | 0.41% | +35.3% |
Q3 2020 | $15,307,000 | +29.3% | 2,335,169 | +16.2% | 0.30% | +16.7% |
Q2 2020 | $11,840,000 | +55.0% | 2,010,169 | 0.0% | 0.26% | +4.0% |
Q1 2020 | $7,639,000 | -27.3% | 2,010,169 | 0.0% | 0.25% | -16.6% |
Q4 2019 | $10,503,000 | +63.2% | 2,010,169 | 0.0% | 0.30% | +39.0% |
Q3 2019 | $6,436,000 | +99.6% | 2,010,169 | +45.1% | 0.21% | +117.3% |
Q2 2019 | $3,224,000 | +95.0% | 1,385,169 | +187.4% | 0.10% | +71.9% |
Q1 2019 | $1,653,000 | +63.3% | 481,971 | +0.0% | 0.06% | +26.7% |
Q4 2018 | $1,012,000 | -32.3% | 481,970 | 0.0% | 0.04% | -18.2% |
Q3 2018 | $1,494,000 | -18.0% | 481,970 | -0.0% | 0.06% | -27.6% |
Q2 2018 | $1,822,000 | – | 481,971 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Soleus Capital Management, L.P. | 4,223,799 | $26,103,000 | 3.37% |
MPM BioImpact LLC | 660,892 | $4,084,000 | 1.10% |
BVF INC/IL | 3,695,629 | $22,839,000 | 0.91% |
Omega Fund Management, LLC | 328,196 | $2,028,000 | 0.42% |
Eventide Asset Management | 4,170,259 | $25,772,000 | 0.40% |
Frazier Life Sciences Management, L.P. | 692,910 | $4,282,000 | 0.36% |
Bellevue Group AG | 5,034,814 | $31,115,000 | 0.36% |
RTW INVESTMENTS, LP | 2,637,192 | $16,298,000 | 0.34% |
Avidity Partners Management LP | 2,460,000 | $15,203,000 | 0.32% |
Rhenman & Partners Asset Management AB | 410,923 | $2,540,000 | 0.25% |